Alzheimer’s disease as type 3 diabetes: understanding the link and implications

Cites (302)

Items 201–300 of 300

1. Metformin Ameliorates Synaptic Defects in a Mouse Model of AD by Inhibiting Cdk5 Activity
   Yali Wang, Jianhua Zhao, Fangli Guo, XiaHuan Gao, Xin’e Xie, ShouQing Liu, Xin Yang, Yang Xinfeng, LuYi Zhang, YuXiao Ye et al. · 2020 · Frontiers in Cellular Neuroscience
2. Linking Alzheimer's disease and type 2 diabetes: Novel shared susceptibility genes detected by cFDR approach
   Xia-Fang Wang, Lin Xu, Ding‐You Li, Rou Li Zhou, Jonathan Greenbaum, Yuancheng Chen, Chun‐Ping Zeng, Lin‐Ping Peng, Ke‐Hao Wu, Zeng‐Xin Ao et al. · 2017 · Journal of the Neurological Sciences
3. Diabetes duration and the risk of dementia: a cohort study based on German health claims data
   Constantin Reinke, Nikolaus Buchmann, Anne Fink, Christina Tegeler, Ilja Demuth, Gabriele Doblhammer · 2021 · Age and Ageing
4. The Neuroprotective Effect of Liraglutide is Mediated by Glucagon-Like Peptide 1 Receptor-Mediated Activation of cAMP/PKA/CREB Pathway
   Bao, Yi, Jiang, Lei, Chen, Haiyan, Zou, Junjie, Liu, Zhimin, Shi, Yongquan · 2015 · Cellular Physiology and Biochemistry
5. Comparison of clinical characteristics between familial and non-familial early onset Alzheimer’s disease
   Simantini J. Karve, John Matthew Ringman, Albert S. Lee, Kevin O. Juarez, Mario F. Mendez · 2012 · Journal of Neurology
6. Neuroprotective effects of liraglutide against inflammation through the AMPK/NF-κB pathway in a mouse model of Parkinson’s disease
   Bing Cao, Yanqiu Zhang, Jinhu Chen, Pengyue Wu, Yuxuan Dong, Yanqin Wang · 2021 · Metabolic Brain Disease
7. Alzheimer’s Disease and Type 2 Diabetes Mellitus: The Use of MCT Oil and a Ketogenic Diet
   Junpei Takeishi, Yasuko Tatewaki, Taizen Nakase, Yumi Takano, Naoki Tomita, Shuzo Yamamoto, Tatsushi Mutoh, Yasuyuki Taki · 2021 · International Journal of Molecular Sciences
8. Mitochondria and Oxidative Stress as a Link between Alzheimer’s Disease and Diabetes Mellitus
   Ivan M. Veselov, Daria V. Vinogradova, Andrey V. Maltsev, Pavel N. Shevtsov, Elena A. Spirkova, Сергей Олегович Бачурин, E. F. Shevtsova · 2023 · International Journal of Molecular Sciences
9. The Pioglitazone Trek via Human PPAR Gamma: From Discovery to a Medicine at the FDA and Beyond
   Pallavi R. Devchand, Tianyun Liu, Russ Biagio Altman, Garret A. FitzGerald, Eric E. Schadt · 2018 · Frontiers in Pharmacology
10. Insulin resistance and impaired lipid metabolism as a potential link between diabetes and Alzheimer's disease
    Joshua A. Kulas, Thaddeus K. Weigel, Heather Anne Ferris · 2020 · Drug Development Research
11. Mechanisms of neurodegeneration — Insights from familial Alzheimer’s disease
    Lucía Chávez‐Gutiérrez, María Szaruga · 2020 · Seminars in Cell and Developmental Biology
12. Liraglutide Reduces Vascular Damage, Neuronal Loss, and Cognitive Impairment in a Mixed Murine Model of Alzheimer’s Disease and Type 2 Diabetes
    María José Carranza-Naval, Àngel del Marco, Carmen Hierro‐Bujalance, Pilar Alves-Martínez, Carmen Infante‐Garcia, María Vargas-Soria, Marta Herrera, Belen Barba-Cordoba, Isabel Atienza‐Navarro, Simón Pedro Lubián‐López et al. · 2021 · Frontiers in Aging Neuroscience
13. Obesity-Associated Neurodegeneration Pattern Mimics Alzheimer’s Disease in an Observational Cohort Study
    Filip Morys, Alzheimer’s Disease Neuroimaging Initiative, Olivier Potvin, Yashar Zeighami, Jacob W. Vogel, Rémi Lamontagne‐Caron, Simon Duchesne, Alain Dagher · 2022 · Journal of Alzheimer s Disease
14. Efficacy of Ketogenic Diets on Type 2 Diabetes: a Systematic Review
    Delphine Tinguely, Justine Gross, Christophe Kosinski · 2021 · Current Diabetes Reports
15. The impact of heavy alcohol consumption on cognitive impairment in young old and middle old persons
    Fu‐Shun Yen, Shiow‐Ing Wang, Shih-Yi Lin, Yung-Hsiang Chao, James Cheng‐Chung Wei · 2022 · Journal of Translational Medicine
16. Evaluation and targeting of amyloid precursor protein (APP)/amyloid beta (Aβ) axis in amyloidogenic and non-amyloidogenic pathways: A time outside the tunnel
    Hayder Mutter Al-Kuraishy, Majid Sakhi Jabir, Ali Ismail Al-Gareeb, Ali K. Albuhadily, Salim Albukhaty, Ghassan Mohammad Sulaiman, Gaber El‐Saber Batiha · 2023 · Ageing Research Reviews
17. Vitamin C supplementation for diabetes management: A comprehensive narrative review
    Mason, Shaun A., Parker, Lewan, van der Pligt, Paige, Wadley, Glenn D. · 2023 · Free Radical Biology and Medicine
18. Alcohol Use Disorder as a Risk Factor for Cognitive Impairment
    Ge Wang, Daniel Y. Li, David E. Vance, Wei Li · 2023 · Journal of Alzheimer s Disease
19. Hypertension and Alzheimer's disease: is the picture any clearer?
    Matthew J. Lennon, Rebecca Koncz, Perminder Singh Sachdev · 2020 · Current Opinion in Psychiatry
20. Alzheimer's disease diagnosis and management: Perspectives from around the world
    Diana R. Kerwin, Carla Abdelnour Ruiz, Paulo Caramelli, Adesola O. Ogunniyi, Jiong Shi, Henrik Zetterberg, Martin Traber · 2022 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
21. A role for sodium glucose cotransporter 2 inhibitors (SGLT2is) in the treatment of Alzheimer's disease?
    RUSSELL L. ESTERLINE, Jan Oscarsson, Jeffrey Murray Burns · 2020 · International review of neurobiology
22. Islet amyloid polypeptide cross-seeds tau and drives the neurofibrillary pathology in Alzheimer’s disease
    Guoxin Zhang, Lanxia Meng, Zhihao Wang, Qinyu Peng, Guiqin Chen, Jing Xiong, Zhentao Zhang · 2022 · Molecular Neurodegeneration
23. Insulin resistance in Alzheimer’s disease: The genetics and metabolomics links
    Arwa M. Amin, Hamza Mohamed Amin Mostafa, Hani M. J. Khojah · 2022 · Clinica Chimica Acta
24. Unraveling the Genetic Landscape of Neurological Disorders: Insights into Pathogenesis, Techniques for Variant Identification, and Therapeutic Approaches
    Zeba Firdaus, Xiaogang Li · 2024 · International Journal of Molecular Sciences
25. The clinical significance of plasma clusterin and Aβ in the longitudinal follow-up of patients with Alzheimer’s disease
    Jung‐Lung Hsu, Wei‐Ju Lee, Yi‐Chu Liao, Shuu‐Jiun Wang, Jong‐Ling Fuh · 2017 · Alzheimer s Research & Therapy
26. Presenilin mutations and their impact on neuronal differentiation in Alzheimer’s disease
    Alejandro Arturo Canales-Aguirre, Mercedes Azucena Hernández-Sapiéns, Edwin Estefan Reza-Zaldívar, Ana Laura Márquez-Aguirre, Ulises Gómez‐Pinedo, Jorge Matías‐Guiu, Ricardo R. Cevallos, Juan Carlos Mateos‐Díaz, Víctor Sánchez-González · 2021 · Neural Regeneration Research
27. Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis
    Mohammad Tahseen Al Bataineh, Axel Künstner, Nihar Ranjan Dash, Habiba S. AlSafar, Mohab Ragab, Franziska Schmelter, Christian Sina, Hauke S. Busch, Saleh Mohamed Ibrahim · 2023 · Scientific Reports
28. Empagliflozin Induced Ketosis, Upregulated IGF-1/Insulin Receptors and the Canonical Insulin Signaling Pathway in Neurons, and Decreased the Excitatory Neurotransmitter Glutamate in the Brain of Non-Diabetics
    Konstantinos Ioannis Avgerinos, Roger J. Mullins, Michael P. Vreones, Maja Mustapić, Qinghua Chen, Denise L. Melvin, Dimitrios Kapogiannis, Josephine Mary Egan · 2022 · Cells
29. Blood Pressure, Antihypertensive Use, and Late-Life Alzheimer and Non-Alzheimer Dementia Risk
    Matthew J. Lennon, Darren M. Lipnicki, Ben C. P. Lam, John D. Crawford, Aletta Elisabeth Schutte, Ruth K Peters, Therese Rydberg Sterner, Jenna Najar, Ingmar Gr. Skoog, Steffi Gerlinde Riedel-Heller et al. · 2024 · Neurology
30. Dynamic Blood Concentrations of Aβ1–40 and Aβ1–42 in Alzheimer’s Disease
    Yang, Yuan-Han, Huang, Ling-Chun, Hsieh, Sun-Wung, Huang, Li-Ju · 2020 · Frontiers in Cell and Developmental Biology
31. High glucose induces tau hyperphosphorylation in hippocampal neurons via inhibition of ALKBH5-mediated Dgkh m6A demethylation: a potential mechanism for diabetic cognitive dysfunction
    Minli Qu, Linhui Zuo, Mengru Zhang, Peng Cheng, Zhanjun Guo, Junya Yang, Changjun Li, Jing Wu · 2023 · Cell Death and Disease
32. Lung endothelium, tau, and amyloids in health and disease
    Ron Balczon, Mike T. Lin, Sarah B. Voth, Amy R. Nelson, Jonas C. Schupp, Brant M. Wagener, Jean‐François Pittet, Troy Stevens · 2023 · Physiological Reviews
33. A Systematic Review of Semaglutide’s Influence on Cognitive Function in Preclinical Animal Models and Cell-Line Studies
    Raluca Oana Tipa, Daniela-Gabriela Bălan, Mihai Géorgescu, Luciana Angela Ignat, Ileana Adela Văcăroiu, Dragos Eugen Georgescu, Laura Răducu, Doina Andrada Mihai, Liviu Vasile Chiperi, Andra-Elena Balcangiu‐Stroescu · 2024 · International Journal of Molecular Sciences
34. Pioglitazone Use and Reduced Risk of Dementia in Patients With Diabetes Mellitus With a History of Ischemic Stroke
    Junghee Ha, Dong‐Woo Choi, Kwang Joon Kim, Keun You Kim, Chung Mo Nam, Eosu Kim · 2023 · Neurology
35. Alcohol Toxicity in Diabetes and Its Complications: A Double Trouble?
    Srikar Munukutla, Guodong Pan, Mandar Deshpande, Rajarajan A. Thandavarayan, Prasanna Krishnamurthy, Suresh S. Palaniyandi · 2016 · Alcoholism Clinical and Experimental Research
36. Impact of Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i) Therapy on Dementia and Cognitive Decline
    Antonio Lardaro, Ludovica Quarta, Stefania Pagnotta, Giorgio Sodero, Sandro Mariani, Maria Del Ben, Giovambattista Desideri, Evaristo Ettorre, Francesco Baratta · 2024 · Biomedicines
37. Inflammatory proteins associated with Alzheimer’s disease reduced by a GLP1 receptor agonist: a post hoc analysis of the EXSCEL randomized placebo controlled trial
    Ivan G. Koychev, Graham Reid, Maggie Nguyen, Robert John Mentz, Dan W. Joyce, Svati Hasmukh Shah, Rury R. Holman · 2024 · Alzheimer s Research & Therapy
38. Changes in Cerebrospinal Fluid Tau and β-Amyloid Levels in Diabetic and Prediabetic Patients: A Meta-Analysis
    Yanhui Lu, Xinjun Jiang, Shilin Liu, Mingzi Li · 2018 · Frontiers in Aging Neuroscience
39. Hypertension and Alzheimer’s disease: indirect effects through circle of Willis atherosclerosis
    Graham M.L. Eglit, Alexandra J. Weigand, Daniel A. Nation, Mark William Bondi, Katherine J. Bangen · 2020 · Brain Communications
40. Nosocomial Pneumonia Elicits an Endothelial Proteinopathy: Evidence for a Source of Neurotoxic Amyloids in Critically Ill Patients
    Mike T. Lin, Ron Balczon, Jean‐François Pittet, Brant M. Wagener, Stephen A. Moser, Kyle Adam Morrow, Sarah B. Voth, C. Michael Francis, Silas J. Leavesley, Jessica Bell et al. · 2018 · American Journal of Respiratory and Critical Care Medicine
41. Interplay between Alzheimer’s disease and global glucose metabolism revealed by the metabolic profile alterations of pancreatic tissue and serum in APP/PS1 transgenic mice
    Xia Liu, Wei Wang, Huali Chen, Haiyan Zhang, Nai-xia Zhang · 2019 · Acta Pharmacologica Sinica
42. Diabetes mellitus and risk of early‐onset Alzheimer's disease: a population‐based case–control study
    Kimiko Kadohara, Izumi Sato, Koji Kawakami · 2017 · European Journal of Neurology
43. Tau suppresses microtubule-regulated pancreatic insulin secretion
    Salvatore P. Mangiafico, Qing‐zhang Tuo, Xiao-Lan Li, Yu Liu, Christian Haralambous, Xulong Ding, Scott Ayton, Qing Wang, D. Ross Laybutt, Jeng Yie Chan et al. · 2023 · Molecular Psychiatry
44. Brain insulin resistance and Alzheimer’s disease: a systematic review
    Luís Jesuíno de Oliveira Andrade, Luís Matos de Oliveira, Alcina Maria Vinhaes Bittencourt, Letícia Góes de Carvalho Lourenço, Gabriela Correia Matos de Oliveira · 2024 · Dementia & Neuropsychologia
45. Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization
    Yeonwoo Chung, Hyunju Lee, the Alzheimer’s Disease Neuroimaging Initiative, Michael Walter Weiner, Paul S. S. Aisen, Ronald Carl Petersen, Cliford R. Jack, William J. Jagust, John Q. Trojanowki, Arthur W. Toga et al. · 2021 · Scientific Reports
46. Diabetes, Hypertension, and the Risk of Dementia
    Fu‐Shun Yen, James Cheng‐Chung Wei, Hei‐Tung Yip, Chii‐Min Hwu, Chih‐Cheng Hsu · 2022 · Journal of Alzheimer s Disease
47. The Interplay between Diabetes and Alzheimer’s Disease—In the Hunt for Biomarkers
    Adriana Kubis-Kubiak, Aleksandra J. Dyba, Agnieszka Piwowar · 2020 · International Journal of Molecular Sciences
48. Aberrant splicing of PSEN2 , but not PSEN1 , in individuals with sporadic Alzheimer’s disease
    Meredith M. Course, Kathryn M. Gudsnuk, Christopher Dirk Keene, Thomas D. Bird, Suman Jayadev, Paul N. Valdmanis · 2022 · Brain
49. Cognitive decline and alcohol consumption in the aging population—A longitudinal analysis of the Survey of Health, Ageing and Retirement in Europe
    Stephan Listabarth, Magdalena Groemer, Thomas Waldhoer, Benjamin Vyssoki, Nathalie Pruckner, Sandra Vyssoki, Alexander Glahn, Deirdre Maria König-Castillo, Daniel König · 2022 · European Psychiatry
50. Feasibility and preliminary efficacy of different intensities of functional training in elderly type 2 diabetes patients with cognitive impairment: a pilot randomised controlled trial
    Majid Mardaniyan Ghahfarrokhi, Hossein Shirvani, Mostafa Rahimi, Behzad Bazgir, Alireza Shamsadini, Vahid Sobhani · 2024 · BMC Geriatrics
51. Ketogenic diet attenuates spatial and item memory impairment in pentylenetetrazol-kindled rats
    Yan Jiang, Yuqiang Lu, Mengmeng Jia, Xiaohang Wang, Zhengxiang Zhang, Qun Hou, Baohui Wang · 2016 · Brain Research
52. The effects of the ketogenic diet for the management of type 2 diabetes mellitus: A systematic review and meta-analysis of recent studies
    Kimberley Yu Ching Choy, Jimmy Chun Yu Louie · 2023 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
53. Dapagliflozin for the treatment of type 2 diabetes mellitus – an update
    Martha Nicholson, Randa Ghazal Asswad, John P.H. Wilding · 2021 · Expert Opinion on Pharmacotherapy
54. The Ketogenic Effect of SGLT-2 Inhibitors—Beneficial or Harmful?
    Michail Koutentakis, Jakub Kuciński, Damian Świeczkowski, Stanisław Surma, Krzysztof Jerzy Filipiak, Aleksandra Gąsecka · 2023 · Journal of Cardiovascular Development and Disease
55. Unlocking the Potential: Semaglutide’s Impact on Alzheimer’s and Parkinson’s Disease in Animal Models
    Andreea-Daniela Meca, Ianis Kevyn Ştefan Boboc, Liliana Mititelu-Tarțău, Mária Bogdán · 2024 · Current Issues in Molecular Biology
56. Infection‐induced endothelial amyloids impair memory
    Ron Balczon, Jean‐François Pittet, Brant M. Wagener, Stephen A. Moser, Sarah B. Voth, Charles V. Vorhees, Michael T. Williams, James P. Bridges, Diego F. Alvarez, Anna Koloteva et al. · 2019 · The FASEB Journal
57. Effects of presenilin-1 familial Alzheimer’s disease mutations on γ-secretase activation for cleavage of amyloid precursor protein
    Hung Nguyen Do, Sujan Devkota, Apurba Bhattarai, Michael S. Wolfe, Yinglong Miao · 2023 · Communications Biology
58. Combination of alcohol and glucose consumption as a risk to induce reactive hypoglycemia
    Chiho Oba‐Yamamoto, Jun Takeuchi, Akinobu Nakamura, Ryoko Takikawa, Ayano Ozaki, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, Tatsuya Atsumi, Hideaki Miyoshi · 2020 · Journal of Diabetes Investigation
59. Effects of Hypertension on Alzheimer’s Disease and Related Disorders
    Joseph E. Malone, Mohamed Elkasaby, Alan Jay Lerner · 2022 · Current Hypertension Reports
60. Pharmacological Approaches Using Diabetic Drugs Repurposed for Alzheimer’s Disease
    Muna A. Adem, Boris Decourt, Marwan Noel Sabbagh · 2024 · Biomedicines
61. Changes in Physical Activity and the Risk of Dementia in Patients With New-Onset Type 2 Diabetes: A Nationwide Cohort Study
    Jung Eun Yoo, Kyungdo Han, Bongseong Kim, Sang Hyun Park, Seon Mee Kim, Hye Soon Park, Ga Eun Nam · 2022 · Diabetes Care
62. Mapping the dynamics of insulin-responsive pathways in the blood–brain barrier endothelium using time-series transcriptomics data
    Zengtao Wang, Xiaojia Tang, Suresh Kumar Swaminathan, Karunya K. Kandimalla, Krishna R. Kalari · 2022 · npj Systems Biology and Applications
63. Insulin blood-brain barrier transport and interactions are greater following exercise in mice
    Caitlin Brown, Sarah Pemberton, Alice Babin, Noor Abdulhameed, Cassidy Noonan, Mary Beth Brown, William A. Banks, Elizabeth M. Rhea · 2022 · Journal of Applied Physiology
64. Association of late-life body mass index with the risk of Alzheimer disease: a 10-year nationwide population-based cohort study
    Su Hwan Cho, Min Jang, HyoRim Ju, Min Ju Kang, Jae Moon Yun, Jae Won Yun · 2022 · Scientific Reports
65. Exendin-4 Prevents Memory Loss and Neuronal Death in Rats with Sporadic Alzheimer-Like Disease
    Adriana Maria Zago, Fabiano B. Carvalho, Francine Luciano Rahmeier, Marta Santin, Giuliano Rizzotto Guimarães, Jessié Martins Gutierres, Marilda da Cruz Fernandes · 2023 · Molecular Neurobiology
66. Insulin Receptor Expression and Activity in the Brains of Nondiabetic Sporadic Alzheimer’s Disease Cases
    Ho, Lap, Yemul, Shrishailam, Knable, Lindsay, Katsel, Pavel, Zhao, Rudy, Haroutunian, Vahram, Pasinetti, Giulio Maria · 2012 · International Journal of Alzheimer's Disease
67. Effect of Ketogenic Diet on Quality of Life in Adults with Chronic Disease: A Systematic Review of Randomized Controlled Trials
    Myriam Abboud, Fatme Al Anouti, Evridiki Georgaki, Dimitrios Papandreou · 2021 · Nutrients
68. Sleep and Late-Onset Alzheimer’s Disease: Shared Genetic Risk Factors, Drug Targets, Molecular Mechanisms, and Causal Effects
    Dongze Chen, Xinpei Wang, Tao Huang, Tao Huang · 2022 · Frontiers in Genetics
69. Screening exons 16 and 17 of the amyloid precursor protein gene in sporadic early-onset Alzheimer's disease
    Imelda Barber, Jennyfer M. Garcí­a-Cárdenas, Chidchanok Sakdapanichkul, Christopher Deacon, Gabriela Zapata Erazo, Rita João Guerreiro, José Brás, Dena G. Hernandez, Andrew Singleton, Tamar Guetta‐Baranes et al. · 2015 · Neurobiology of Aging
70. Regulation of microRNAs in Alzheimer´s disease, type 2 diabetes, and aerobic exercise training
    Ricardo Augusto Leoni De Sousa, Alex Cleber Improta Caria · 2022 · Metabolic Brain Disease
71. Association between cumulative smoking exposure and cognitive decline in non-demented older adults: NEDICES study
    Julián Benito‐León, Ritwik Ghosh, José Lapeña-Motilva, Cristina Martín-Arriscado, Félix Bermejo‐Pareja · 2023 · Scientific Reports
72. Efficacy and safety of brexpiprazole for the treatment of agitation in Alzheimer's disease: a meta-analysis of randomized controlled trials
    Gabriel Marinheiro, Julyana Medeiros Dantas, Antonio Marcondes Mutarelli², Artur Menegaz de Almeida, Gabriel de Almeida Monteiro, Djinane Spinosa Zerlotto, João Paulo Mota Telles · 2024 · Neurological Sciences
73. Impact of Cigarette Smoking and Its Interaction with Hypertension and Diabetes on Cognitive Function in Older Americans
    Daniel Restifo, Chen Zhao, Hooman Kamel, Costantino Iadecola, Neal S. Parikh · 2022 · Journal of Alzheimer s Disease
74. Associations of Physical Activity with Alzheimer’s Disease Pathologies and Cognition: The CABLE Study
    Zhong Shuang, Bing Tian Zhao, Ya‐Hui Ma, Yan Sun, Yongli Zhao, Wenhui Liu, Ya‐Nan Ou, Qiang Dong, Lan Tan, Jin‐Tai Yu · 2022 · Journal of Alzheimer s Disease
75. Diabetes mellitus contributes to higher cerebrospinal fluid tau levels selectively in Alzheimer's disease patients with the APOE4 genotype
    Caterina Motta, Martina Assogna, Chiara Giuseppina Bonomi, Alfredo Paolo Mascolo, Vincenzo De Lucia, Roberta Semprini, Nicola Biagio Mercuri, Giacomo Koch, Alessandro Martorana · 2021 · European Journal of Neurology
76. Empagliflozin for the treatment of type 2 diabetes mellitus: An overview of safety and efficacy based on P hase 3 trials 艾格列净治疗2型糖尿病：基于3期试验的安全性与有效性概述
    GEORGE E. DAILEY · 2015 · Journal of Diabetes
77. Deciphering an interplay of proteins associated with amyloid β 1-42 peptide and molecular mechanisms of Alzheimer’s disease
    Luis Fernando Hernández-Zimbrón, Selva Rivas-Arancibia · 2014 · Reviews in the Neurosciences
78. Pioglitazone use increases risk of Alzheimer's disease in patients with type 2 diabetes receiving insulin
    Hsin‐Chung Lin, Chi‐Hsiang Chung, Lih‐Chyang Chen, Jui‐Yang Wang, Chien‐Chou Chen, Kuo‐Yang Huang, Ming-Hang Tsai, Wu‐Chien Chien, Hsin‐An Lin · 2023 · Scientific Reports
79. Brexpiprazole for Agitation Associated With Dementia Due to Alzheimer's Disease
    Daniel C. Lee, Emily D. Clark, Inga Margret Antonsdottir, Anton P. Porsteinsson · 2024 · Journal of the American Medical Directors Association
80. Role of Biliverdin Reductase A in the Regulation of Insulin Signaling in Metabolic and Neurodegenerative Diseases: An Update
    Flavia Agata Cimini, Marzia Perluigi A, Ilaria Barchetta, Maria Gisella Cavallo, Eugenio Barone · 2022 · International Journal of Molecular Sciences
81. Hepatic and cardiac implications of increased toxic amyloid-beta serum level in lipopolysaccharide-induced neuroinflammation in rats: new insights into alleviating therapeutic interventions
    Mai M. Anwar, Abeer A. Mabrouk · 2023 · Inflammopharmacology
82. Cigarette smoking and cardiovascular disease incidence and all-cause mortality: the modifying role of diet quality
    Mostafa Norouzzadeh, Farshad Teymoori, Hossein Farhadnejad, Nazanin Moslehi, Parvin Mirmiran, Seyedeh Tayebeh Rahideh, Fereidoun Azizi · 2024 · BMC Public Health
83. Nutritional intervention for diabetes mellitus with Alzheimer's disease
    Zhi Li, Simian Li, Ying Xiao, Tian Zhong, Xi Yu, Ling Wang · 2022 · Frontiers in Nutrition
84. Revealing genetic links of Type 2 diabetes that lead to the development of Alzheimer’s disease
    Muhammad Afzal, Khalid Saad Alharbi, Sami Ibrahim Alzarea, Najiah M. Alyamani, Imran Ahmed Kazmi, Emine Güven · 2022 · Heliyon
85. Plasma Clusterin as a Potential Biomarker for Alzheimer’s Disease-A Systematic Review and Meta-analysis
    Xinrui Shi, Beijia Xie, Yi Xing, Yi Tang · 2019 · Current Alzheimer Research
86. Pathogenic connection between hypertension and type 2 diabetes: how do they mutually affect each other?
    Atsushi Tanaka, Koichi Node · 2022 · Hypertension Research
87. A feasibility study of the combination of intranasal insulin with oral semaglutide for cognition in older adults with metabolic syndrome at high dementia risk- Study rationale and design.
    Tal Davidy, Iscka Yore, T. Cukierman-Yaffe, R. Ravona-Springer, A. Livny, Orit H. Lesman-Segev, Yossi Azuri, Owen Carmichael, Dimitrios Kapogiannis, H. Zetterberg et al. · 2023 · Mechanisms of Ageing and Development
88. Intensive versus standard blood pressure control in type 2 diabetes: a restricted mean survival time analysis of a randomised controlled trial
    Sandra Shi, Natalia Gouskova, Mehdi Najafzadeh, Lee‐Jen Wei, Dae Hyun Kim · 2021 · BMJ Open
89. Senescent adipocytes and type 2 diabetes – current knowledge and perspective concepts
    Weronika Kruczkowska, Julia Gałęziewska, Mateusz Kciuk, Adrianna Gielecińska, Elżbieta Płuciennik, Zbigniew Włodzimierz Pasieka, Lin-Yong Zhao, Yi-Jin Yu, Damian Kołat, Żaneta Kałuzińska‐Kołat · 2024 · BioMolecular Concepts
90. Research trend of microbiota-gut-brain axis in Alzheimer’s disease based on CiteSpace (2012–2021): A bibliometrics analysis of 608 articles
    Zilong Li, Haotian Ma, Meng Wang, Yi‐Hua Qian · 2022 · Frontiers in Aging Neuroscience
91. The mitochondrial quality control system: a new target for exercise therapeutic intervention in the treatment of brain insulin resistance-induced neurodegeneration in obesity
    Ming Cai, Jian Wan, Keren Cai, Shuyao Li, Xinlin Du, Haihan Song, Wanju Sun, Jingyun Hu · 2024 · International Journal of Obesity
92. Differential responses of primary neuron-secreted MCP-1 and IL-9 to type 2 diabetes and Alzheimer’s disease-associated metabolites
    Brendan K. Ball, Madison K. Kuhn, Rebecca M. Fleeman Bechtel, Elizabeth A. Proctor, Douglas K. Brubaker · 2024 · Scientific Reports
93. Advances in the Therapeutic Potential of Inhibitors Targeting Glycogen Synthase Kinase 3 in Inflammatory Diseases
    Yifan Zhu, Hui Wang, Yueyue Guo, Jie Cao, Huanqiu Li · 2023 · Mini-Reviews in Medicinal Chemistry
94. Effect of different blood glucose intervention plans on elderly people with type 2 diabetes mellitus combined with dementia.
    Y Chen, J Wang, Wang Lj, Ho Lin, Huang Pj · 2017 · PubMed
95. Amyloid beta emerges from below the neck to disable the brain
    Grant Kauwe, Tara E. Tracy · 2021 · PLoS Biology
96. The Effect of Holistic Therapy in Alzheimer's Disease.
    Mümüne Merve Parlak, Özlem Bizbinar, Ayşen Köse · 2023 · PubMed
97. Clinical characteristics and genotype-phenotype correlation analysis of familial Alzheimer’s disease patients with pathogenic/likely pathogenic amyloid protein precursor mutations
    Yingzi Liu, Xuewen Xiao, Hui Liu, Xinxin Liao, Yafang Zhou, Ling Weng, Lu Zhou, Xixi Liu, Xiangyun Bi, Tianyan Xu et al. · 2022 · Frontiers in Aging Neuroscience
98. Tau in the pancreas: understanding the link between type 2 diabetes mellitus and Alzheimer’s disease
    Wenlu Li, Steffen Tiedt, Eng H. Lo · 2023 · Signal Transduction and Targeted Therapy
99. The effects of endurance exercise and metformin on memory impairment caused by diabetes
    Sadegh Shabab, Maryam Mahmoudabady, Mahmoud Hosseini, Zahra Gholamnezhad, Mahtab Fouladi, Ali Akbar Asghari · 2023 · Hormone Molecular Biology and Clinical Investigation
100. High-Fat Diet-Induced Diabetic Conditions Exacerbate Cognitive Impairment in a Mouse Model of Alzheimer's Disease Via a Specific Tau Phosphorylation Pattern
     Yuki Ito, Shuko Takeda, Tsuneo Nakajima, A. Oyama, Haruo Takeshita, Kazumasa Miki, Yoichi Takami, Yasushi Takeya, Munehisa Shimamura, Hiromi Rakugi et al. · 2023 · The Journal of Prevention of Alzheimer s Disease